Evidence map›Paper›PMID 21132370›Full record

ArticleAnnals of biomedical engineering2011

Multifunctional FePt nanoparticles for radiation-guided targeting and imaging of cancer.

Ghazal Hariri, Matthew S Wellons, William H Morris, Charles M Lukehart, Dennis E Hallahan

Abstract read
In one paragraph

Article in Annals of biomedical engineering, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Tumor-targeting peptides from combinatorial libraries.Advanced drug delivery reviews · 2017
    Review
  6. Review
  7. Technology for Innovation in Radiation Oncology.International journal of radiation oncology, biology, physics · 2015
    Article
  8. Nanotechnology in radiation oncology.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2014
    Review
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ghazal HaririDepartment of Chemistry, Vanderbilt University, Nashville, TN 37235, USA.
Matthew S Wellons
William H Morris
Charles M Lukehart
Dennis E Hallahan

Funding

Vanderbilt In Vivo Cellular and Molecular Imaging CenterP50CA128323 · NCI · VANDERBILT UNIVERSITY · PI SHYR, YU · 2008 to 2012
$6.8M
X-ray Targeted Therapeutic Genes within NanoparticlesR01CA125757 · NCI · WASHINGTON UNIVERSITY · PI HALLAHAN, DENNIS E · 2007 to 2011
$1.7M
Pharmacodynamic Assessment of RTK Inhibitors in CancerR01CA112385 · NCI · WASHINGTON UNIVERSITY · PI HALLAHAN, DENNIS E · 2005 to 2009
$1.3M
Nanoparticles Targeting Pancreatic CancerR21CA128456 · NCI · WASHINGTON UNIVERSITY · PI HALLAHAN, DENNIS E · 2007 to 2009
$422k
NCI NIH HHS P50 CA128323NCI NIH HHS R01 CA112385NCI NIH HHS R01CA112385NCI NIH HHS R01 CA125757NCI NIH HHS R01-CA125757NCI NIH HHS R21 CA128456NCI NIH HHS R21-CA128456
6 · The paper itself

Abstract

A multifunctional FePt nanoparticle was developed that targets tumor microvasculature via "radiation-guided" peptides, and is detected by both near-infrared (NIR) fluorescence imaging and analytical mass spectrometry methods. Tumor specific binding was first measured by biotinylated peptide linked to fluorophore-conjugated streptavidin. This showed tumor selective binding to tumors using the HVGGSSV peptide. FePt nanoparticles were synthesized sequentially by surface modification with poly(L)lysine, poly(ethylene) glycol conjugation, and functionalized with HVGGSSV peptide and fluorescent probe Alexa fluor 750. NIR fluorescence imaging and ICP-MS analysis showed significant HVGGSSV-FePt nanoparticle binding to irradiated tumors as compared to unirradiated tumors and controls. Results indicate that multifunctional FePt nanoparticles have potential application for radiation-guided targeting and imaging of cancer.

Indexed as

Molecular Probe TechniquesAnimalsCell Line, TumorHumansIronLung NeoplasmsMetal NanoparticlesMiceMice, NudeMicroscopy, FluorescenceOrgan SpecificityPlatinumTissue DistributionTreatment OutcomeIronPlatinum

Identifiers

PMID21132370
PMCPMC4401085

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.